{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T07:02:20Z","timestamp":1795071740186,"version":"4.10.2"},"reference-count":80,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:p>\n                    Neuroendocrine neoplasms (NENs) of the cervix are rare aggressive tumors associated with poor prognosis and only limited treatment options. Although there is some literature on molecular underpinnings of cervical small cell neuroendocrine carcinomas (SCNECs), detailed morphologic and associated molecular characteristics of cervical NENs remains to be elucidated. Herein, 14 NENs (SCNEC: 6, large cell neuroendocrine carcinoma [LCNEC]: 6, neuroendocrine tumor [NET]: 2), including 5 admixed with human papillomavirus (HPV)-associated adenocarcinoma (carcinoma admixed with neuroendocrine carcinoma) were analyzed. All except 3 SCNECs were HPV16\/18 positive.\n                    <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                    (3) and\/or\n                    <jats:italic toggle=\"yes\">RB1<\/jats:italic>\n                    (4) alterations (3 concurrent) were only seen in SCNECs (4\/6) and were enriched in the HPV16\/18-negative tumors. The other most common molecular changes in neuroendocrine carcinomas (NECs) overlapping with those reported in the literature for cervical carcinomas involved PI3K\/MAPK pathway (4) and\n                    <jats:italic toggle=\"yes\">MYC<\/jats:italic>\n                    (4) and were seen in both SCNECs and LCNECs. In contrast, the 2 NETs lacked any significant alterations. Two LCNECs admixed with adenocarcinoma had enough material to sequence separately each component. In both pathogenic alterations were shared between the 2 components, including\n                    <jats:italic toggle=\"yes\">ERBB2<\/jats:italic>\n                    amplification in one and an\n                    <jats:italic toggle=\"yes\">MSH6<\/jats:italic>\n                    mutation with\n                    <jats:italic toggle=\"yes\">MYC<\/jats:italic>\n                    amplification in the other. Overall, these findings suggest that cervical HPV-associated NETs are genomically silent and high-grade NECs (regardless of small or large cell morphology) share molecular pathways with common cervical carcinomas as it has been reported in the endometrium and are different from NECs at other sites. Molecular analysis of these highly malignant neoplasms might inform the clinical management for potential therapeutic targets.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000001943","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T12:07:45Z","timestamp":1662552465000},"page":"1670-1681","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":24,"title":["Morphologic and Molecular Heterogeneity of Cervical Neuroendocrine Neoplasia"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3218-1075","authenticated-orcid":false,"given":"Zehra","family":"Ordulu","sequence":"first","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Mino-Kenudson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Van de Vijver","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ghent University Hospital and Cancer Research Institute Ghent (CRIG), Ghent, Belgium"},{"name":"Department of Gynecologic Oncology, Center for Gynecologic Oncology Amsterdam (CGOA), Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Franco","family":"Zannoni","sequence":"additional","affiliation":[{"name":"Department of Pathology, Catholic University of the Sacred Hearth, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"F\u00e9lix","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nova Medical School and University of Lisbon, Portuguese Institute of Oncology of Lisbon, Francisco Gentil, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike","family":"Burandt","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, KK Women\u2019s and Children\u2019s Hospital, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Nardi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Oliva","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/PGP.0000000000000132","article-title":"A rare case of HPV-negative cervical squamous cell carcinoma","volume":"34","author":"Casey","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/PAS.0000000000000986","article-title":"International Endocervical Adenocarcinoma Criteria and Classification (IECC): A new pathogenetic classification for invasive adenocarcinomas of the endocervix","volume":"42","author":"Stolnicu","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAS.0000000000001095","article-title":"International endocervical adenocarcinoma criteria and classification: validation and interobserver reproducibility","volume":"43","author":"Hodgson","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2886","article-title":"Human papillomavirus oncoproteins: pathways to transformation","volume":"10","author":"Moody","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature21386","article-title":"Integrated genomic and molecular characterization of cervical cancer","volume":"543","author":"Cancer Genome Atlas Research","year":"2017","journal-title":"Nature"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/cncr.28288","article-title":"Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix","volume":"119","author":"Wright","year":"2013","journal-title":"Cancer"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/1066896916643385","article-title":"Neuroendocrine Carcinoma of the Cervix: Review of a Series of Cases and Correlation With Outcome","volume":"24","author":"Ganesan","year":"2016","journal-title":"Int J Surg Pathol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ygyno.2016.12.003","article-title":"Neuroendrocrine tumors of the uterine cervix: A therapeutic challenge for gynecologic oncologists","volume":"144","author":"Gadducci","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00000478-199101000-00003","article-title":"Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus type 18-associated cancer","volume":"15","author":"Stoler","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/jcp.55.2.108","article-title":"Detection of human papillomavirus in large cell neuroendocrine carcinoma of the uterine cervix: a study of 12 cases","volume":"55","author":"Grayson","year":"2002","journal-title":"J Clin Pathol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pvr.2018.03.005","article-title":"Contribution of Human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases","volume":"5","author":"Alejo","year":"2018","journal-title":"Papillomavirus Res"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/00000478-199708000-00004","article-title":"Large cell neuroendocrine [corrected] carcinoma of the uterine cervix: a clinicopathologic study of 12 cases","volume":"21","author":"Gilks","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1053\/adpa.2002.36661","article-title":"Small cell carcinoma of the cervix: a clinicopathologic and immunohistochemical study of 23 cases","volume":"6","author":"Conner","year":"2002","journal-title":"Ann Diagn Pathol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/01.PGP.0000071046.12278.D1","article-title":"Large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathological study of six cases","volume":"22","author":"Sato","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PGP.0b013e31815de006","article-title":"Small cell carcinomas and large cell neuroendocrine carcinomas of the endometrium and cervix: polypoid tumors and those arising in polyps may have a favorable prognosis","volume":"27","author":"Albores-Saavedra","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11912-017-0617-2","article-title":"Pathology of neuroendocrine tumours of the female genital tract","volume":"19","author":"Howitt","year":"2017","journal-title":"Curr Oncol Rep"},{"key":"R20-20250608","article-title":"\u201cNeuroendocrine tumor grade 3 (net g3)\u201d of the uterine cervix: a report of 2 cases","author":"Katafuchi","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","DOI":"10.1097\/PGP.0000000000000851","article-title":"Low-grade neuroendocrine tumor of the cervix: report of 3 cases of a rare neoplasm with review of the literature","author":"Sah","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"8095","DOI":"10.18632\/oncotarget.14098","article-title":"Cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing","volume":"8","author":"Cho","year":"2017","journal-title":"Oncotarget"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ygyno.2016.04.001","article-title":"Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer","volume":"141","author":"Frumovitz","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/PAS.0000000000001042","article-title":"Next-generation sequencing reveals recurrent somatic mutations in small cell neuroendocrine carcinoma of the uterine cervix","volume":"42","author":"Xing","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"e0234505","DOI":"10.1371\/journal.pone.0234505","article-title":"Comparative genomics of high grade neuroendocrine carcinoma of the cervix","volume":"15","author":"Hillman","year":"2020","journal-title":"PLoS One"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/1878-0261.12962","article-title":"Genomic characterization of small cell carcinomas of the uterine cervix","volume":"16","author":"Schultheis","year":"2021","journal-title":"Mol Oncol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/PAI.0000000000000884","article-title":"Molecular Profiling Reveals Limited Targetable Biomarkers in Neuroendocrine Carcinoma of the Cervix","volume":"29","author":"Cimic","year":"2021","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3390\/cancers13061215","article-title":"Comparative analysis of genetic alterations, hpv-status, and pd-l1 expression in neuroendocrine carcinomas of the cervix","volume":"13","author":"Takayanagi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R29-20250608","first-page":"PO.19.00248","article-title":"Unique genomic landscape of high-grade neuroendocrine cervical carcinoma: implications for rethinking current treatment paradigms","volume":"4","author":"Eskander","year":"2020","journal-title":"JCO Precis Oncol"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.2396","article-title":"Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer","volume":"44","author":"Peifer","year":"2012","journal-title":"Nat Genet"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/PAS.0b013e3182417d36","article-title":"Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors","volume":"36","author":"Yachida","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2162-3619-4-2","article-title":"Distinct genetic alterations in small cell carcinoma from different anatomic sites","volume":"4","author":"Zheng","year":"2015","journal-title":"Exp Hematol Oncol"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1634\/theoncologist.2016-0517","article-title":"Exceptional response to nivolumab and stereotactic body radiation therapy (sbrt) in neuroendocrine cervical carcinoma with high tumor mutational burden: management considerations from the Center For Personalized Cancer Therapy At UC San Diego Moores Cancer Center","volume":"22","author":"Sharabi","year":"2017","journal-title":"Oncologist"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/gyno.1998.5248","article-title":"Molecular abnormalities associated with endocrine tumors of the uterine cervix","volume":"72","author":"Wistuba","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13000-019-0837-x","article-title":"Clinicopathological characteristics and molecular abnormalities of primary grade 2 neuroendocrine tumors of the cervix","volume":"14","author":"Zhu","year":"2019","journal-title":"Diagn Pathol"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","article-title":"A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal","volume":"31","author":"Rindi","year":"2018","journal-title":"Mod Pathol"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/cancers12051211","article-title":"Neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and immunohistochemical study with focus on novel markers (SST2-SST5)","volume":"12","author":"Inzani","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/nm.3729","article-title":"Anchored multiplex PCR for targeted next-generation sequencing","volume":"20","author":"Zheng","year":"2014","journal-title":"Nat Med"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ijgo.12969","article-title":"Corrigendum to \u201cRevised FIGO staging for carcinoma of the cervix uteri\u201d [Int J Gynecol Obstet 145(2019) 129-135]","volume":"147","author":"Bhatla","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"R42-20250608","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"R43-20250608","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1038\/s41467-021-24043-6","article-title":"Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes","volume":"12","author":"Li","year":"2021","journal-title":"Nat Commun"},{"key":"R44-20250608","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41422-018-0039-1","article-title":"The genomic landscape of small cell carcinoma of the esophagus","volume":"28","author":"Wang","year":"2018","journal-title":"Cell Res"},{"key":"R45-20250608","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/jamaoto.2013.3210","article-title":"High frequency of activating PIK3CA mutations in human papillomavirus-positive oropharyngeal cancer","volume":"139","author":"Nichols","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R46-20250608","doi-asserted-by":"crossref","first-page":"e92071","DOI":"10.1371\/journal.pone.0092071","article-title":"KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC)","volume":"9","author":"Casadei Gardini","year":"2014","journal-title":"PLoS One"},{"key":"R47-20250608","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","author":"Cancer Genome Atlas","year":"2015","journal-title":"Nature"},{"key":"R48-20250608","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/s41379-021-00869-9","article-title":"Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma","volume":"34","author":"Ohmoto","year":"2021","journal-title":"Mod Pathol"},{"key":"R49-20250608","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ng.2405","article-title":"Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer","volume":"44","author":"Rudin","year":"2012","journal-title":"Nat Genet"},{"key":"R50-20250608","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"R51-20250608","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.celrep.2014.05.012","article-title":"APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development","volume":"7","author":"Henderson","year":"2014","journal-title":"Cell Rep"},{"key":"R52-20250608","first-page":"10548","article-title":"APOBEC3A possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer","volume":"8","author":"Chen","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"R53-20250608","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3390\/ijms22031402","article-title":"HPV Meets APOBEC: New Players in Head and Neck Cancer","volume":"22","author":"Riva","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R54-20250608","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.18632\/oncotarget.14533","article-title":"Identification and characterization of HPV-independent cervical cancers","volume":"8","author":"Banister","year":"2017","journal-title":"Oncotarget"},{"key":"R55-20250608","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41379-018-0131-6","article-title":"Identification of high-risk human papillomavirus and Rb\/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma","volume":"32","author":"Shamir","year":"2019","journal-title":"Mod Pathol"},{"key":"R56-20250608","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.athoracsur.2007.03.093","article-title":"Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma","volume":"84","author":"Iyoda","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"R57-20250608","doi-asserted-by":"crossref","first-page":"8774","DOI":"10.1200\/JCO.2005.02.8233","article-title":"Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung","volume":"23","author":"Rossi","year":"2005","journal-title":"J Clin Oncol"},{"key":"R58-20250608","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1158\/1078-0432.CCR-15-2946","article-title":"Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets","volume":"22","author":"Rekhtman","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R60-20250608","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"key":"R61-20250608","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"key":"R62-20250608","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1447-0756.2010.01402.x","article-title":"Atypical metastatic carcinoid of the uterine cervix and review of the literature","volume":"37","author":"Yoshida","year":"2011","journal-title":"J Obstet Gynaecol Res"},{"key":"R63-20250608","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.gynor.2013.10.003","article-title":"Atypical carcinoid of the uterine cervix with aggressive clinical behavior: A case report","volume":"7","author":"Yasuoka","year":"2014","journal-title":"Gynecol Oncol Case Rep"},{"key":"R64-20250608","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11912-021-01062-6","article-title":"Update on histological reporting changes in neuroendocrine neoplasms","volume":"23","author":"Brautigam","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"R65-20250608","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1038\/s41467-019-11276-9","article-title":"Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids","volume":"10","author":"Alcala","year":"2019","journal-title":"Nat Commun"},{"key":"R66-20250608","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1158\/0008-5472.CAN-19-0214","article-title":"Integrative genomic characterization identifies molecular subtypes of lung carcinoids","volume":"79","author":"Laddha","year":"2019","journal-title":"Cancer Res"},{"key":"R69-20250608","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/PAS.0000000000000169","article-title":"Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases","volume":"38","author":"Basturk","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R70-20250608","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/PAS.0000000000000408","article-title":"The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms","volume":"39","author":"Basturk","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R71-20250608","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1158\/1078-0432.CCR-15-0548","article-title":"Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: a pathway distinct from poorly differentiated neuroendocrine carcinomas","volume":"22","author":"Tang","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R72-20250608","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2020.12.008","article-title":"Neuroendocrine carcinoma and mixed neuroendocrinenon-neuroendocrine neoplasm of the stomach: a clinicopathological and exome sequencing study","volume":"110","author":"Ishida","year":"2021","journal-title":"Hum Pathol"},{"key":"R73-20250608","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/modpathol.2016.220","article-title":"Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas","volume":"30","author":"Jesinghaus","year":"2017","journal-title":"Mod Pathol"},{"key":"R74-20250608","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1158\/1078-0432.CCR-16-0355","article-title":"Genomic profiling of large-cell neuroendocrine carcinoma of the lung","volume":"23","author":"Miyoshi","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R75-20250608","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/PAS.0000000000001560","article-title":"Molecular characterization of neuroendocrine carcinomas of the endometrium: representation in all 4 tcga groups","volume":"44","author":"Howitt","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R76-20250608","doi-asserted-by":"crossref","first-page":"661034","DOI":"10.3389\/fonc.2021.661034","article-title":"Case report: re-sensitization to gefitinib in lung adenocarcinoma harboring egfr mutation and high pd-l1 expression after immunotherapy resistance, which finally transform into small cell carcinoma","volume":"11","author":"Zhai","year":"2021","journal-title":"Front Oncol"},{"key":"R77-20250608","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/PGP.0000000000000254","article-title":"Cervical carcinomas with neuroendocrine differentiation: a report of 28 cases with immunohistochemical analysis and molecular genetic evidence of common clonal origin with coexisting squamous and adenocarcinomas","volume":"35","author":"Emerson","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"R78-20250608","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PGP.0000000000000306","article-title":"Mixed mesonephric adenocarcinoma and high-grade neuroendocrine carcinoma of the uterine cervix: case description of a previously unreported entity with insights into its molecular pathogenesis","volume":"36","author":"Cavalcanti","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"R79-20250608","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/1097-0142(19880315)61:6<1171::AID-CNCR2820610620>3.0.CO;2-X","article-title":"The histologic diagnosis of adenocarcinoma in situ and related lesions of the cervix uteri. Adenocarcinoma in situ","volume":"61","author":"Jaworski","year":"1988","journal-title":"Cancer"},{"key":"R81-20250608","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s12885-018-4447-x","article-title":"Neuroendocrine carcinoma of the cervix: a systematic review of the literature","volume":"18","author":"Tempfer","year":"2018","journal-title":"BMC Cancer"},{"key":"R82-20250608","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ygyno.2021.04.039","article-title":"Neuroendocrine tumors of the gynecologic tract update","volume":"162","author":"Winer","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R83-20250608","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ygyno.2020.05.682","article-title":"Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract","volume":"158","author":"Frumovitz","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R84-20250608","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gore.2014.09.003","article-title":"Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation","volume":"10","author":"Lyons","year":"2014","journal-title":"Gynecol Oncol Rep"},{"key":"R85-20250608","doi-asserted-by":"crossref","first-page":"100499","DOI":"10.1016\/j.gore.2019.100499","article-title":"Treatment of neuroendocrine carcinoma of the cervix with a PARP inhibitor based on next generation sequencing","volume":"30","author":"Rose","year":"2019","journal-title":"Gynecol Oncol Rep"},{"key":"R87-20250608","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001943","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T17:02:42Z","timestamp":1749402162000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001943"}},"subtitle":["A Report of 14 Cases"],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":80,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001943","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,5]]}}}